• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性腹裂婴儿的益生菌给药:一项初步随机安慰剂对照试验

Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial.

作者信息

Powell Weston T, Borghese Robyn A, Kalanetra Karen M, Mirmiran Majid, Mills David A, Underwood Mark A

机构信息

Department of Pediatrics, University of California Davis, Sacramento, CA.

Department of Food Science and Technology, University of California Davis, Davis, CA.

出版信息

J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):852-857. doi: 10.1097/MPG.0000000000001031.

DOI:10.1097/MPG.0000000000001031
PMID:26545203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4854817/
Abstract

OBJECTIVES

Infants with gastroschisis often require long periods of gastric suctioning and hospitalization. The impact of these interventions on the intestinal microbiota and attempts to alter the microbial community have not been studied. We sought to determine how the intestinal microbiota is influenced by the current treatment of gastroschisis and whether alteration of the intestinal microbiota with a probiotic microbe will influence length of hospitalization.

METHODS

We performed a randomized, placebo-controlled pilot study of administration of probiotic Bifidobacterium longum subsp. infantis in 24 infants with gastroschisis. The primary outcome was changes in the fecal microbiota, and the secondary outcome was length of hospital stay.

RESULTS

Administration of the probiotic or placebo was well tolerated, even during the period of gastric suctioning. The overall microbial communities were not significantly different between groups, although analysis of the final specimens by family demonstrated higher Bifidobacteriaceae, lower Clostridiaceae, and trends toward lower Enterobacteriaceae, Enterococcaceae, Staphylococcaceae, and Streptococcaceae in the probiotic group. Clinical outcomes, including length of hospital stay, did not differ between groups.

CONCLUSIONS

In this pilot study, there was significant in infants with gastroschisis that was partially attenuated by the administration of B longum subsp. infantis.

摘要

目的

腹裂婴儿通常需要长时间的胃肠减压和住院治疗。这些干预措施对肠道微生物群的影响以及改变微生物群落的尝试尚未得到研究。我们试图确定腹裂目前的治疗方法如何影响肠道微生物群,以及用益生菌改变肠道微生物群是否会影响住院时间。

方法

我们对24例腹裂婴儿进行了一项随机、安慰剂对照的益生菌婴儿双歧杆菌亚种给药试验研究。主要结局是粪便微生物群的变化,次要结局是住院时间。

结果

即使在胃肠减压期间,益生菌或安慰剂的给药耐受性也良好。尽管按菌科对最终样本进行分析显示,益生菌组的双歧杆菌科较高、梭菌科较低,且肠杆菌科、肠球菌科、葡萄球菌科和链球菌科有降低趋势,但两组的总体微生物群落无显著差异。两组的临床结局,包括住院时间,没有差异。

结论

在这项试验研究中,腹裂婴儿存在显著变化,给予婴儿双歧杆菌亚种可部分减轻这种变化。

相似文献

1
Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial.先天性腹裂婴儿的益生菌给药:一项初步随机安慰剂对照试验
J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):852-857. doi: 10.1097/MPG.0000000000001031.
2
Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial.健康母乳喂养婴儿中补充婴儿双歧杆菌亚种(婴儿双歧杆菌)的膳食研究:一项随机对照试验的研究方案。
Trials. 2016 Jul 22;17(1):340. doi: 10.1186/s13063-016-1467-1.
3
Bifidobacterium longum subsp infantis CECT7210-supplemented formula reduces diarrhea in healthy infants: a randomized controlled trial.长双歧杆菌亚种婴儿 CECT7210 配方奶粉可减少健康婴儿腹泻:一项随机对照试验。
Pediatr Res. 2018 Jun;83(6):1120-1128. doi: 10.1038/pr.2018.34. Epub 2018 May 2.
4
Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial.先天性腹裂婴儿的益生菌给药:一项随机安慰剂对照试验的初步研究
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):e210. doi: 10.1097/MPG.0000000000001381.
5
Response to Letter to the Editor Regarding "Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial".对关于“先天性腹裂婴儿的益生菌给药:一项随机安慰剂对照试验”的致编辑信的回复
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):e210. doi: 10.1097/MPG.0000000000001392.
6
Early Probiotic Supplementation of Healthy Term Infants with subsp. M-63 Is Safe and Leads to the Development of -Predominant Gut Microbiota: A Double-Blind, Placebo-Controlled Trial.早期益生菌补充剂(M-63 亚种)对健康足月婴儿是安全的,并导致以双歧杆菌为主的肠道微生物群的发展:一项双盲、安慰剂对照试验。
Nutrients. 2023 Mar 14;15(6):1402. doi: 10.3390/nu15061402.
7
The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.多菌种益生菌混合物对腹泻型肠易激综合征症状和粪便微生物群的影响:一项随机、双盲、安慰剂对照试验。
J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1.
8
Probiotic administration in congenital heart disease: a pilot study.益生菌在先天性心脏病中的应用:一项初步研究。
J Perinatol. 2013 Sep;33(9):691-7. doi: 10.1038/jp.2013.41. Epub 2013 Apr 18.
9
Probiotic supplementation in neonates with major gastrointestinal surgical conditions: a systematic review.
J Matern Fetal Neonatal Med. 2018 Jun;31(11):1517-1523. doi: 10.1080/14767058.2017.1317738. Epub 2017 Apr 25.
10
Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.摄入加氏乳杆菌KS-13、两歧双歧杆菌G9-1和长双歧杆菌MM-2可诱导老年人产生炎症细胞因子水平降低,并使肠道微生物群发生潜在有益转变:一项随机、双盲、安慰剂对照、交叉研究。
J Am Coll Nutr. 2015;34(6):459-69. doi: 10.1080/07315724.2014.983249. Epub 2015 Apr 24.

引用本文的文献

1
Microbiota-Modulating Strategies in Neonates Undergoing Surgery for Congenital Gastrointestinal Conditions: A Narrative Review.先天性胃肠道疾病手术新生儿的微生物群调节策略:一项叙述性综述
Nutrients. 2025 Jul 5;17(13):2234. doi: 10.3390/nu17132234.
2
Individual and Combined Effects of 2'-Fucosyllactose and Bifidobacterium longum subsp. infantis on the Gut Microbiota Composition of Piglets.2'-岩藻糖基乳糖与婴儿双歧杆菌亚种对仔猪肠道微生物群组成的个体及联合作用
J Nutr. 2025 Feb;155(2):509-522. doi: 10.1016/j.tjnut.2024.12.022. Epub 2024 Dec 27.
3
A 36-week preterm newborn with gastroschisis: a rare case report.一名患有腹裂的36周早产儿:一例罕见病例报告。
J Surg Case Rep. 2025 Apr 23;2025(4):rjaf234. doi: 10.1093/jscr/rjaf234. eCollection 2025 Apr.
4
Feeding practices for infants with gastroschisis: A survey of neonatal intensive care units in Canada.腹裂婴儿的喂养方法:加拿大新生儿重症监护病房的一项调查。
J Neonatal Perinatal Med. 2025 Jul;18(4):312-320. doi: 10.1177/19345798251327370. Epub 2025 Mar 17.
5
Impact of Subspecies on Pediatric Gut Health and Nutrition: Current Evidence and Future Directions.亚种对儿科肠道健康和营养的影响:当前证据和未来方向。
Nutrients. 2024 Oct 16;16(20):3510. doi: 10.3390/nu16203510.
6
Probiotics for the postoperative management of term neonates after gastrointestinal surgery.益生菌在经胃肠道手术后足月新生儿的术后处理中的应用。
Cochrane Database Syst Rev. 2024 Jan 23;1(1):CD012265. doi: 10.1002/14651858.CD012265.pub2.
7
Safety, efficacy, and impact on gut microbial ecology of a subspecies LMG11588 supplementation in healthy term infants: a randomized, double-blind, controlled trial in the Philippines.健康足月儿补充亚种LMG11588的安全性、有效性及其对肠道微生物生态的影响:菲律宾的一项随机、双盲、对照试验
Front Nutr. 2023 Dec 14;10:1319873. doi: 10.3389/fnut.2023.1319873. eCollection 2023.
8
Translating neonatal microbiome science into commercial innovation: metabolism of human milk oligosaccharides as a basis for probiotic efficacy in breast-fed infants.将新生儿微生物组科学转化为商业创新:人乳寡糖的代谢作为母乳喂养婴儿益生菌功效的基础。
Gut Microbes. 2023 Jan-Dec;15(1):2192458. doi: 10.1080/19490976.2023.2192458.
9
Efficacy of alone or in multi-strain probiotic formulations during early life and beyond.单一菌株或多菌株益生菌制剂在生命早期及生命后期的功效。
Gut Microbes. 2023 Jan-Dec;15(1):2186098. doi: 10.1080/19490976.2023.2186098.
10
Probiotic supplementation for neonates with congenital gastrointestinal surgical conditions: guidelines for future research.先天性胃肠道外科疾病新生儿的益生菌补充:未来研究的指南。
Pediatr Res. 2023 Jan;93(1):49-55. doi: 10.1038/s41390-022-02087-8. Epub 2022 May 3.

本文引用的文献

1
Potential role of the intestinal microbiota in programming health and disease.肠道微生物群在健康和疾病中的潜在作用。
Nutr Rev. 2015 Aug;73 Suppl 1:32-40. doi: 10.1093/nutrit/nuv039.
2
Diet shapes the gut microbiome of pigs during nursing and weaning.饮食在哺乳和断奶期间塑造了猪的肠道微生物组。
Microbiome. 2015 Jul 1;3:28. doi: 10.1186/s40168-015-0091-8. eCollection 2015.
3
Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut.婴儿双歧杆菌亚种:婴儿肠道的优势定植菌。
Pediatr Res. 2015 Jan;77(1-2):229-35. doi: 10.1038/pr.2014.156. Epub 2014 Oct 10.
4
The long term physical consequences of gastroschisis.腹裂的长期身体后果。
J Pediatr Surg. 2014 Oct;49(10):1466-70. doi: 10.1016/j.jpedsurg.2014.03.008.
5
Stool microbiota and vaccine responses of infants.婴儿的粪便微生物群与疫苗反应
Pediatrics. 2014 Aug;134(2):e362-72. doi: 10.1542/peds.2013-3937. Epub 2014 Jul 7.
6
Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota.婴儿双歧杆菌亚种在实验性坏死性小肠结肠炎中的作用:炎症、先天免疫反应及微生物群的改变
Pediatr Res. 2014 Oct;76(4):326-33. doi: 10.1038/pr.2014.102. Epub 2014 Jul 7.
7
Intestinal dysbiosis: novel mechanisms by which gut microbes trigger and prevent disease.肠道微生物失调:肠道微生物引发和预防疾病的新机制。
Prev Med. 2014 Aug;65:133-7. doi: 10.1016/j.ypmed.2014.05.010. Epub 2014 May 20.
8
The neonatal bowel microbiome in health and infection.健康与感染状态下的新生儿肠道微生物群
Curr Opin Infect Dis. 2014 Jun;27(3):236-43. doi: 10.1097/QCO.0000000000000061.
9
Probiotics for prevention of necrotizing enterocolitis in preterm infants.益生菌用于预防早产儿坏死性小肠结肠炎
Cochrane Database Syst Rev. 2014 Apr 10(4):CD005496. doi: 10.1002/14651858.CD005496.pub4.
10
Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children.益生元和益生菌:儿童特应性皮炎的预防及严重程度降低
Benef Microbes. 2014 Jun 1;5(2):151-60. doi: 10.3920/BM2013.0034.